Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)
EUROPEAN JOURNAL OF HEART FAILURE, vol.22, no.11, pp.1984-1986, 2020 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 22 Issue: 11
- Publication Date: 2020
- Doi Number: 10.1002/ejhf.2026
- Journal Name: EUROPEAN JOURNAL OF HEART FAILURE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
- Page Numbers: pp.1984-1986
- Keywords: Heart failure, Sodium–, glucose co‐, transporter 2 inhibitors, Type 2 diabetes mellitus, Cardiovascular outcomes, Renal function
- Eskisehir Osmangazi University Affiliated: Yes
Abstract
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued a position paper on the role of sodium-glucose co-transporter 2 (SGLT2) inhibitors in heart failure (HF). The present document provides an update of the position paper, based of new clinical trial evidence. Accordingly, the following recommendations are given: